|Document ID (ISN)||102279|
|Convention or series no.
Inter-Organization Programme for the Sound Management of Chemicals (IOMC)
||Elemental mercury and inorganic mercury compounds: Human health aspects
||World Health Organization, Distribution and Sales Service, 1211 Genève 27, Switzerland, 2003. iv, 61p. 298 ref.
||03-1091.pdf [in English]
http://www.who.int/ipcs/publications/cicad/en/cicad50.pdf [in English]
||Conclusions of this criteria document: mild subclinical signs of central nervous toxicity can be observed among workers exposed to elemental mercury at a concentration of 20µg/m3 or above for several years. Neurological and behavioural disorders have been observed following inhalation of elemental mercury vapour or dermal application of inorganic mercury-containing medicinal products. The primary effect of long-term oral exposure to low amounts of inorganic mercury compounds is renal damage; immunological effects have also been shown. Data from animal studies indicate that mercuric chloride has some carcinogenic activity in male rats; parenteral administration of inorganic mercury compounds is embryotoxic and teratogenic in rodents. Inorganic mercury compounds seem to interact with and damage DNA in vitro.
||IPCS; health hazards; toxicology; mercury and compounds
||toxic effects; criteria document; literature survey; ILO; UNEP; WHO; mercuric chloride; mercury chloride; mercury; mercuric acetate; renal damage; ecotoxicology; animal experiments; lethal concentration 50; mercury sulfide; neurotoxic effects
||B - Chemical safety information sheets
|Country / State or Province||USA; WHO|
||Toxic and dangerous substances
|Broad subject area(s)
||Mercury and compounds